Your session is about to expire
← Back to Search
LASIK
Contoura with Phorcides and WaveLight Wavefront Optimized for Near-sightedness and Astigmatism
N/A
Recruiting
Research Sponsored by Daniel Terveen
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-op
Awards & highlights
Summary
This trial compares two laser eye surgery techniques in patients looking to improve their vision. Both methods use lasers to reshape the cornea, enhancing visual clarity and patient satisfaction. One of the methods used in this trial has been shown to provide excellent visual outcomes.
Eligible Conditions
- Near-sightedness
- Astigmatism
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months post-op
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-op
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Post-Op UDVA
Secondary study objectives
Corrected Distance Visual Acuity
Low Contrast Visual Acuity
Post-OP BCVA
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Study: PhorcidesExperimental Treatment1 Intervention
Contoura with Phorcides used for surgical planning of LASIK procedure
Group II: Control: Wavefront OptimizedActive Control1 Intervention
WaveLight Wavefront Optimized used for surgical planning of LASIK procedure
Find a Location
Who is running the clinical trial?
Daniel TerveenLead Sponsor
Alcon ResearchIndustry Sponsor
726 Previous Clinical Trials
128,365 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had eye surgery in the past.You have a condition called strabismus or amblyopia.You are in good health overall, including your eyes.You cannot have LASIK surgery if you have severe dry eye, problems with your cornea, uncontrolled glaucoma, certain medical conditions like diabetes, or a history of herpes.You have a disease that affects your immune system.You are pregnant or currently breastfeeding.The study only includes participants with normal vision (no need for glasses) in both eyes.
Research Study Groups:
This trial has the following groups:- Group 1: Control: Wavefront Optimized
- Group 2: Study: Phorcides
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger